Last Updated: September 24, 2026

Details for New Drug Application (NDA): 017874

✉ Email this page to a colleague

NDA 017874 describes TRANSDERM SCOP, which is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. It is available from one supplier. Additional details are available on the TRANSDERM SCOP profile page.

The generic ingredient in TRANSDERM SCOP is scopolamine. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the scopolamine profile page.

Summary for 017874

Tradename:	TRANSDERM SCOP
Applicant:	Baxter Hlthcare Corp
Ingredient:	scopolamine
Patents:	0

Pharmacology for NDA: 017874

Mechanism of Action	Cholinergic Antagonists

Suppliers and Packaging for NDA: 017874

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874	NDA	Baxter Healthcare Corporation	10019-008	10019-008-01	1 PATCH in 1 POUCH (10019-008-01) / 3 d in 1 PATCH
TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874	NDA	Baxter Healthcare Corporation	10019-008	10019-008-04	4 POUCH in 1 BOX (10019-008-04) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TRANSDERMAL			Strength	1MG/72HR
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 017874

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.